These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21862738)

  • 1. Meth use linked to risk of Parkinson disease.
    Kuehn BM
    JAMA; 2011 Aug; 306(8):814. PubMed ID: 21862738
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence of Parkinson's disease among hospital patients with methamphetamine-use disorders.
    Callaghan RC; Cunningham JK; Sajeev G; Kish SJ
    Mov Disord; 2010 Oct; 25(14):2333-9. PubMed ID: 20737543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methamphetamine and meth mouth: an overview.
    Williams N; Covington JS
    J Tenn Dent Assoc; 2006; 86(4):32-5. PubMed ID: 17228534
    [No Abstract]   [Full Text] [Related]  

  • 4. Meth mouth: methamphetamine and oral health.
    Padilla R; Ritter AV
    J Esthet Restor Dent; 2008; 20(2):148-9. PubMed ID: 18380848
    [No Abstract]   [Full Text] [Related]  

  • 5. Meth--it's everybody's problem.
    Harris MH
    S D J Med; 2003 Sep; 56(9):375-6. PubMed ID: 14524136
    [No Abstract]   [Full Text] [Related]  

  • 6. Meth mouth: a national scourge.
    Mallatt ME
    J Indiana Dent Assoc; 2005; 84(3):28-9. PubMed ID: 16359093
    [No Abstract]   [Full Text] [Related]  

  • 7. Meth mouth.
    Heng CK; Badner VM; Schiop LA
    N Y State Dent J; 2008; 74(5):50-1. PubMed ID: 18982966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methamphetamine: geographic areas and populations at risk, and emerging evidence for effective interventions.
    Degenhardt L; Baker A; Maher L
    Drug Alcohol Rev; 2008 May; 27(3):217-9. PubMed ID: 18368601
    [No Abstract]   [Full Text] [Related]  

  • 9. Meth: What You Should Know.
    Am Fam Physician; 2018 Jul; 98(2):Online. PubMed ID: 30216002
    [No Abstract]   [Full Text] [Related]  

  • 10. The burden and management of crystal meth use.
    Buxton JA; Dove NA
    CMAJ; 2008 Jun; 178(12):1537-9. PubMed ID: 18519899
    [No Abstract]   [Full Text] [Related]  

  • 11. Is methamphetamine abuse a risk factor in parkinsonism?
    Guilarte TR
    Neurotoxicology; 2001 Dec; 22(6):725-31. PubMed ID: 11829406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methamphetamine abuse and "meth mouth".
    Rhodus NL; Little JW
    Northwest Dent; 2005; 84(5):29, 31, 33-7. PubMed ID: 16317979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Features and Outcomes of Methamphetamine-associated Pulmonary Arterial Hypertension.
    Zamanian RT; Hedlin H; Greuenwald P; Wilson DM; Segal JI; Jorden M; Kudelko K; Liu J; Hsi A; Rupp A; Sweatt AJ; Tuder R; Berry GJ; Rabinovitch M; Doyle RL; de Jesus Perez V; Kawut SM
    Am J Respir Crit Care Med; 2018 Mar; 197(6):788-800. PubMed ID: 28934596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methamphetamine--what primary care practitioners need to know.
    McAvoy BR
    J Prim Health Care; 2009 Sep; 1(3):170-6. PubMed ID: 20690379
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs.
    Callaghan RC; Cunningham JK; Sykes J; Kish SJ
    Drug Alcohol Depend; 2012 Jan; 120(1-3):35-40. PubMed ID: 21794992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rotten times are here again!
    Stein WE
    Northwest Dent; 2005; 84(5):10. PubMed ID: 16317976
    [No Abstract]   [Full Text] [Related]  

  • 17. [Amphetamine-induced psychosis or schizophrenia?].
    Rognli EB; Medhus SE; Bramness JG
    Tidsskr Nor Laegeforen; 2015 Feb; 135(3):249-51. PubMed ID: 25668544
    [No Abstract]   [Full Text] [Related]  

  • 18. Pipe dreams: concealed methamphetamine causing severe toxicity.
    Baalachandran R; Hypes C; Natt B; Snyder L
    Am J Med Sci; 2015 Jun; 349(6):548-9. PubMed ID: 25760282
    [No Abstract]   [Full Text] [Related]  

  • 19. Psychiatric comorbidity of methamphetamine dependence in a forensic sample.
    Kalechstein AD; Newton TF; Longshore D; Anglin MD; van Gorp WG; Gawin FH
    J Neuropsychiatry Clin Neurosci; 2000; 12(4):480-4. PubMed ID: 11083165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive Deficits in Methamphetamine Users: How Strong is The Evidence?
    Proebstl L; Kamp F; Koller G; Soyka M
    Pharmacopsychiatry; 2018 Nov; 51(6):243-250. PubMed ID: 29334687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.